Dr. Diana Marisa Delvalle, MD

Dr. Delvalle practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Dr. Delvalle's NPI, 1013079441, was assigned on December 14, 2006. Dr. Delvalle graduated from New York Medical College in 2000. Dr. Delvalle's New York license number on file is 224871.

Dr. Delvalle's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Dr. Delvalle's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Dr. Delvalle is also affiliated with Boca Raton Regional Hospital. The medical group on file is CORA Physical Therapy, Spanish Springs. Dmand AI also links Dr. Delvalle to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delvalle practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Delvalle's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Delvalle is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Delvalle's licenses on file in 2 states: New York and Florida.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Delvalle treats.

CMS data shows 4,177 Medicare services from Dr. Delvalle across 21 procedure codes in 2024, for 989 Medicare patients. Medicare paid $247,251 for them. Every service was in an office.

CMS counts 989 Medicare patients who saw Dr. Delvalle in 2024. The largest group is 75 to 84, with 454 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Delvalle's median patient age at 73, with 59% women.

In 2024, Dr. Delvalle wrote 1,842 Medicare Part D claims for 675 patients. 97% of them were for generic drugs. CMS names the drug for 1,738 of them, across 19 drugs with 11 or more claims each, at $43,795 in total drug cost. In 2023, CMS named 1,681 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Delvalle for performance year 2024, reported individually. Dr. Delvalle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Delvalle as offering telehealth.

CMS Open Payments shows 73 general payments to Dr. Delvalle from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Optinose US, Inc. paid the most, $565.

Dr. Delvalle graduated from New York Medical College in 2000.

Dr. Delvalle is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.